United Kingdom · Question · Written question
UIN 46602
Methylphenidate and Pancreatic Enzyme Replacement Therapy: Import Duties
Introduced
17 April 2025
Last action
29 April 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
29 April 2025
Summary
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of US tariffs on the domestic supply of (a) methylphenidate and (b) pancreatic enzyme replacement therapy.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
17 April 2025
Written question
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of US tariffs on the domestic supply of (a) methylphenidate and (b) pancreatic enzyme replacement therapy.
Source: Commons
29 April 2025
Answer
The Department is working closely with life sciences stakeholders and other Government departments to assess the potential impact of United States tariffs on global medicine supply chains. We have a range of well-established processes to mitigate risks to...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-04-17/46602
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1795173
- uk · wq-1795173 · source updated 29 April 2025